Navigation Links
China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System

BEIJING, March 25 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company received quality testing certificate (the ''Certificate'') for its SPR-based Analysis System (the ''SPR System'') from one of the State Food and Drug Administration (the ''SFDA'') Quality Supervision and Testing Centres yesterday. To receive the Certificate, the Company's SPR System has passed all the safety and performance parameters required by the SFDA.

''The receipt of the Certificate marks an important milestone during the SFDA approval process for our SPR System,'' said Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. ''We will continue to work on the approval process which includes the commencement of 120 clinical trial samples by three SFDA authorized Tier-1 hospitals and subsequent administrative procedures by the SFDA before its approval. Meanwhile, we have commenced the clinical trial for our HPV-DNA Biosensor Chip. Another three SFDA authorized Tier-1 hospitals have collected over 1,000 clinical samples required by the SFDA to conduct the testing for our HPV Chip. They have processed about one- third of the samples and will continue to finish the remaining samples to submit the results for our SFDA approval process for our HPV Chip. We expect to receive the respective SFDA approval for our SPR System and HPV Chip before the end of 2009, which is in-line with our previous expectations. We will make announcement for each important milestone upon achievement during the SFDA approval process for both our SPR System and HPV Chip.''

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute ''forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as ''will,'' ''expects,'' ''anticipates,'' ''future,'' ''intends,'' ''plans,'' ''believes,'' ''estimates'' and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

    For more information, please contact

     Winnie Yam
     Tel:   +86-10-6530-8833

SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract
2. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
3. China Medicine Announces Conference Call to Discuss Fourth and Fiscal Year 2008 Results
4. China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores
5. China Nepstar Chain Drugstore Announces Dividend
6. China Sky One Medical to Attend Two Conferences in March
7. China Sky One Medical, Inc. Obtains SFDA Approval for Policresulen Vaginal Suppositories
8. China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
9. China Yingxia International, Inc.s chairwoman and CEO is in talks with investors in China
10. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
11. Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology: